 Oncternal Therapeutics, Inc. Nasdaq: ONCT, a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that it will report first quarter 2020 financial results before U.S. financial markets open on Thursday, May 7, 2020. Oncternals management will host a webcast and conference call at 12:00 p.m. PDT 3:00 p.m. EDT to discuss the Companys financial results and provide a comprehensive business update. The time of the webcast has been changed due to the unusually high demand for conferencing services on this date. 